Golgi Phosphoprotein 2 Down-regulates the Th1 Response in Human Gastric Cancer Cells by Suppressing IL-12A |
Tang, Qing-Feng
(Department of Clinical Laboratories & Experimental Center, Putuo Hospital, Shanghai University of Traditional Chinese Medicine)
Ji, Qing (Department of Clinical Laboratories & Experimental Center, Putuo Hospital, Shanghai University of Traditional Chinese Medicine) Tang, Yu (Department of nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine) Hu, Song-Jiao (Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine) Bao, Yi-Jie (Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine) Peng, Wen (Department of nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine) Yin, Pei-Hao (Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine) |
1 | Fritzsche FR, Riener MO, Dietel M, et al (2008). GOLPH2 expression in renal cell cancer. BMC Urol, 8, 15. DOI ScienceOn |
2 | Airoldi I, Guglielmino R, Carra G, et al (2002). The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes. Haematologica, 87, 434-42. |
3 | Boes M, Prodeus AP, Schmidt T, et al (1998). A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med, 188, 2381-6. DOI |
4 | Clark IA (2007). How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev, 18, 335-43. DOI ScienceOn |
5 | Correa P (2013). Gastric cancer: overview. Gastroenterol Clin North Am, 42, 211-7. DOI |
6 | Fritzsche FR, Kristiansen G, Riener MO, et al (2010). GOLPH2 expression may serve as diagnostic marker in seminomas. BMC Urol, 10, 4. DOI ScienceOn |
7 | Gong Y, Long Q, Xie H, et al (2012). Cloning and characterization of human Golgi phosphoprotein 2 gene (GOLPH2/GP73/GOLM1) promoter. Biochem Biophys Res Commun, 421, 713-20. DOI ScienceOn |
8 | Gray PW, Goeddel DV (1982). Structure of the human immune interferon gene. Nature, 298, 859-63. DOI ScienceOn |
9 | Hu L, Li L, Xie H, et al (2011).The Golgi localization of GOLPH2 (GP73/GOLM1) is determined by the transmembrane and cytoplamic sequences. PLoS One, 6, e28207. DOI |
10 | Kim HJ, Lv D, Zhang Y, et al (2012). Golgi phosphoprotein 2 in physiology and in diseases. Cell Biosci, 2, 31. DOI ScienceOn |
11 | Kim JJ (2013). Upper gastrointestinal cancer and reflux disease. J Gastric Cancer, 13, 79-85. 과학기술학회마을 DOI ScienceOn |
12 | Kristiansen G, Fritzsche FR, Wassermann K, et al (2008). GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer, 99, 939-48. DOI ScienceOn |
13 | Laxman B, Morris DS, Yu J, et al (2008). A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res, 68, 645-9. DOI ScienceOn |
14 | Old LJ (1985). Tumor necrosis factor (TNF). Science, 230, 630-2. DOI |
15 | Peluso I, Pallone F, Monteleone G (2006). Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol, 12, 5606-10. |
16 | Reid RR, Prodeus AP, Khan W, et al (1997). Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol, 159, 970-5. |
17 | Riener MO, Stenner F, Liewen H, et al (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49, 1602-9. DOI ScienceOn |
18 |
Rival YA. Maschio D, Rabiet MJ, et al (1996). Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF- |
19 | Said EA, Dupuy FP, Trautmann L, et al (2010). Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nature Med, 16, 452-9. DOI ScienceOn |
20 | Roobol MJ, Haese A, Bjartell A (2011).Tumour markers in prostate cancer III: biomarkers in urine. Acta Oncol, 50 (Suppl 1), 85-9. DOI ScienceOn |
21 | Wajant H, Pfizenmaier K, Scheurich P (2003). Tumor necrosis factor signaling. Cell Death Differ, 10, 45-65. DOI ScienceOn |
22 | Schoenborn JR, Wilson CB (2007). Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol, 96, 41-101. DOI ScienceOn |
23 | Schroder K, Hertzog PJ, Ravasi T, et al (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol, 75, 163-89. |
24 |
Wang L, Zhao YH, Liu Y, et al (2013). IFN- |
25 | Wei S, Dunn TA, Isaacs WB, et al (2008). GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus. Prostate, 68, 1387-95. DOI ScienceOn |
26 | Wolf SF, Temple PA, Kobayashi M, et al (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol, 146, 3074-81. |
27 | Zhang F, Gu Y, Li X, et al (2010). Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue. Clin Biochem, 43, 983-91. DOI ScienceOn |
28 | Sugano K (2013). Premalignant conditions of gastric cancer. J Gastroenterol Hepatol, 28, 906-11. DOI ScienceOn |
29 |
Romer LH, McLean NV, Yan HC, et al (1995). IFN- |
30 | Pietrantonio F, De Braud F, Da Prat V, et al (2013). A review on biomarkers for prediction of treatment outcome in gastric cancer. Anticancer Res, 33, 1257-66. |
![]() |